Background and basics
1: The epidemiology and pathophysiology of coronary artery disease, Robert Henderson, Richard Varcoe
2: The history of interventional cardiology, Toby Rogers, Kenneth Kent, and Augusto D. Pichard
3: Risk assessment and analysis of outcomes, Peter F. Ludman
4: Vascular access: femoral versus radial, David H. Roberts
5: Radiation and percutaneous coronary intervention, Gurbir Bhatia, James Nolan
6: The 'golden rules' of percutaneous coronary intervention, Rod Stables
7: Routine management after percutaneous coronary intervention, Kevin O'Gallagher, Jonathan Byrne, and Philip MacCarthy
8: Trial design and interpretation: statistics in PCI, Ayman Al-Saleh and Sanjit Jolly
Percutaneous coronary intervention-related imaging
9: Angiography: indications and limitations, David Adlam, Annette Maznyczka, and Bernard Prendergast
10: Coronary physiology in clinical practice, Olivier Muller, Stephane Fournier, Bernard De Bruyne
11: The role of intravascular ultrasound in percutaneous coronary intervention, Hiromasa Otake, Yasuhiro Honda, and Peter J. Fitzgerald
12: Optical Coherence Tomography in Percutaneous Coronary Intervention, Ravinay Bhindi and Keith M. Channon
13: Coronary computed tomography for the interventionalist, A. Coenen, L.E. Swart, R.P.J. Budde, and K. Nieman
14: Cardiovascular magnetic resonance, Theodoros D. Karamitsos and Stefan Neubauer
Percutaneous coronary intervention by clinical syndrome
15: Stable coronary artery disease: medical therapy versus percutaneous coronary intervention versus surgery, Vasim Farooq and Patrick W. Serruys
16: Percutaneous coronary intervention in non-ST elevation acute coronary syndrome, Bashir Alaour, Michael Mahmoudi and Nick Curzen
17: Primary percutaneous coronary intervention for ST elevation myocardial infarction, Zulfiquar Adam and Mark A. de Belder
18: Percutaneous coronary intervention in patients with impaired left ventricular function, Divaka Perera and Natalia Briceno
Percutaneous coronary intervention by lesion and patient subsets
19: Coronary bifurcation stenting: state of the art, Yves Louvard, Philippe Garot, Thomas Hovasse, Bernard Chevalier, and Thierry Lefèvre
20: Percutaneous coronary intervention for unprotected and protected left main stem disease, Michael Mahmoudi, Nick Curzen, Christine Hughes, Bruno Farah, and Jean Fajadet
21: Chronic total occlusions, Colm G. Hanratty, James C. Spratt, Simon J. Walsh
22: Revascularisation in patients with diabetes mellitus, George Kassimis and Adrian P. Banning
23: Out of Hospital Arrest: Role of PCI, Marko Noc and Peter Radsel
Adjunctive drug therapies in percutaneous coronary intervention
24: Current status of oralantiplatelet therapies, Vikram Khanna, Tony Gershlick and Nick Curzen
25: Current status of GP IIb/IIIa inhibitors, Tim Lockie
26: The role of bivalirudin in percutaneous coronary intervention, Stefanie Schüpke, Steffen Massberg, and Adnan Kastrati
27: Optimal medical therapy in percutaneous coronary intervention patients: statins and ACE inhibitors as disease-modifying agents, Simon J. Corbett and Nick Curzen
28: New Oral Anti-Coagulants (NOACs) and other Adjunctive Therapies, Mikhail S. Dzeshka, Richard A. Brown, and Gregory Y.H. Lip
Complications of percutaneous coronary intervention
29: Contrast-induced acute kidney injury, Peter A. McCullough
30: In-stent restenosis in the drug-eluting stent era, Jaya Chandrasekhar, Adriano Caixeta, Philippe Généreux, George Dangas, and Roxana Mehran
31: Stent thrombosis, Nikesh Malik, Amerjeet Banning, and Tony Gershlick
32: Stent loss and retrieval, Adam de Belder
33: Coronary artery perforation, Mark Gunning and Chee Wah Khoo
Special devices in percutaneous coronary intervention
34: Rotational atherectomy, Adam de Belder, Martyn Thomas, and Emanuele Barbato
35: Laser, Peter O'Kane and Simon Redwood
36: Saphenous Vein Graft PCI, Distal Protection and no-reflow, Giovanni Luigi De Maria and Adrian P. Banning
37: Bioresorbable Vascular Scaffolds, Adam J. Brown and Nick E. J. West
38: Access Sites and the TAVI Procedure, Corrado Tamburino, Claudia Ina Tamburino and Sebastiano Immè
39: Selection of TAVI Prostheses, Mohamed Abdel-Wahab and John Jose
40: Co-existent Coronary Artery Disease in Patients Undergoing TAVI: When and When Not to Treat, Muhammed Zeeshan Khawaja and Simon Redwood
41: Transcatheter Mitral Valve Repair, Michael Bellamy and Christopher Baker
42: Transcatheter Mitral Valve Replacement, Ricardo Boix Garibo, Mohsin Uzzaman, Michael Ghosh-Dastidar, and Vinayak Bapat
Other Non-coronary percutaneous interventions
43: Percutaneous device closure of atrial septal defect and patent foramen ovale, Patrick A. Calvert, Bushra S. Rana, Roland Hilling-Smith, and David Hildick-Smith
44: Mitral balloon valvuloplasty, Alec Vahanian, Dominique Himbert, Eric Brochet, Grégory Ducrocq, and Bernard Iung
45: Alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Charles Knight, Saidi Mohiddin, and Constantinos O'Mahony
46: Carotid artery stenting, Iqbal Malik and Mohamed Hamady
47: Left Atrial Appendage Occlusion, Tim Betts
The Future
48: Novel Therapies for Hypertension, Kenneth Chan, Manish Saxena, and Melvin D. Lobo
49: Robotic PCI, Giora Weisz
50: Stem Cell Therapy and Delivery, Fizzah Choudry and Anthony Mathur